Viewing StudyNCT00089661



Ignite Creation Date: 2024-05-05 @ 11:35 AM
Last Modification Date: 2024-10-26 @ 9:10 AM
Study NCT ID: NCT00089661
Status: COMPLETED
Last Update Posted: 2018-10-17
First Post: 2004-08-09

Brief Title: AMG 162 in the Treatment of Bone Loss in Subjects Undergoing Aromatase Inhibitor Therapy for Non-metastatic Breast Cancer
Sponsor: Amgen
Organization: Amgen

Conditions & Keywords Data

Conditions:
Name
Breast Cancer
Low Bone Mineral Density
Osteopenia
Keywords:
Name View
Low bone density View
Breast Cancer View
Bone loss associated with Aromatase Inhibitor therapy AIT for non-metastatic BC View
osteopenia View